FLG works with leading life sciences and healthcare companies, from seed stage to emerging to enterprise. These innovative players are highly focused around fundraising, dealmaking and carefully managing their costs. Rapidly evolving biotech, pharma and medtech clients are typically less focused on generating revenue but have significant regulatory and reporting requirements. These clients require continual fundraising through all phases of growth. Pharma clients also need to know their CFO understands the FDA’s approval path to commercial viability. And familiarity with some of the science behind a drug going to market and what constitutes the total available market for a drug are key. Managing a life science, pharma or medtech company successfully to exit, often through a strategic acquisition scenario, is also a critical skill set for a healthcare sector CFO.
What Our Life Sciences Clients Say
“When I agreed to join Hansen Medical, I knew we faced a multitude of challenges that had to be promptly addressed. As we evaluated the capital needs and cost structure of the company, I needed a CFO who could be a balanced and trusted business partner. I needed someone to ensure my strategy was being implemented effectively, essentially an extension of me. Chris Lowe, my FLG partner, was immediately effective in guiding our financing strategy and implementing our cost reduction plans. The success of these programs allowed us to then pursue a strategic sale. Our achievements could not have been done without FLG’s support.”Cary Vance, CEO, Hansen Medical Inc.